Catalyst Biosciences Inc (NASDAQ: CBIO) stock suffered a major decline of -18.4% on 4/10/24. The shares closed at $13.88. Moreover, exceptionally high trading volume at 273% of normal accompanied the decline. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -18.3% during the last week.
Current PriceTarget Research Rating
CBIO’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment